Higashikagawa, Japan

Masahiro Yamaji

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 5 EPO patents. Top assignees: Teikoku Seiyaku Co., Ltd., Drossapharm Ag, Fuso Pharmaceutical Industries, Ltd.. Active years: 2001-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Yamaji. Retrieved from https://idiyas.com/inventor/masahiro-yamaji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 70.0


 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 83(Granted Patents)


Location History:

  • Kagawa-ken, JP (2001)
  • Ohkawa-gun, JP (2006)
  • Kagawa, JP (2001 - 2014)
  • Higashikagawa, JP (2011 - 2014)

Company Filing History:


Years Active: 2001-2014

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Masahiro Yamaji: Innovator in Transdermal Drug Delivery

Introduction

Masahiro Yamaji is a prominent inventor based in Higashikagawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. With a total of 10 patents to his name, Yamaji's work focuses on enhancing the efficacy and comfort of drug administration.

Latest Patents

One of Yamaji's latest patents is a transdermally absorbable donepezil-containing preparation. This innovative formulation allows for the sustainable administration of donepezil over an extended period. It is designed to provide both a rapid increase in blood levels of donepezil and sustained release properties. The formulation is created by dissolving donepezil in an adhesive patch base that includes a hydrophobic polymer and an absorption promoter. The absorption promoter can be selected from various compounds, including lauryl alcohol and triethyl citrate.

Another notable patent involves external patches containing etofenamate. This invention focuses on creating patches with excellent skin permeability and therapeutic effects while minimizing irritation. The external patch consists of an adhesive layer that combines an adhesive base and the drug, laminated with a backing. The adhesive base is composed of synthetic rubber polymer, adhesive resin, and liquid paraffin, ensuring effective drug delivery.

Career Highlights

Yamaji has worked with reputable companies in the pharmaceutical industry, including Teikoku Seiyaku Co., Ltd. and Fuso Pharmaceutical Industries, Ltd. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.

Collaborations

Throughout his career, Yamaji has collaborated with notable colleagues such as Toshikuni Kawaji and Kenichi Hattori. These partnerships have fostered innovation and advancements in the field of pharmaceuticals.

Conclusion

Masahiro Yamaji's contributions to transdermal drug delivery systems have significantly impacted the pharmaceutical industry. His innovative patents demonstrate his commitment to improving patient care through effective drug administration methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…